Reduced Intensity Transplant Conditioning Regimen for Severe Thalassemia

NCT01005576 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Severe Thalassemia

Interventions

DRUG: Transplant conditioning regimen of alemtuzumab, fludarabine, and melphalan

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]